Sherif Mohamed El-Refai  - Pharmacist


Current location

United States

Work category

Pharmaceutical and Science



Sherif Mohamed El-Refai 's Blog

The Black Lab Aims to Improve Cancer Therapies

on 01 Sep 2015 19:43 | Viewed 331 times

Sherif Mohamed El-Refai is pursuing a PhD in pharmaceutical sciences at the University of Kentucky. His concentration is on clinical and experimental therapeutics. Concurrently, Sherif Mohamed El-Refai works in the university's Markey Cancer Center and participates in the Black Lab.

Established in 2004, the Black Lab, named for geneticist Dr. Esther P. Black, includes students enrolled in health programs at the University of Kentucky. Members focus on studying cancer therapies through control of gene expression. The lab's goal is to improve patient response to therapy by conducting and evaluating data from wet-lab experiments that utilize tumor samples.

The lab has generated numerous publications on a variety of subjects since its inception, including a Phase II study of combined fulvestrant and everolimus in patients with a metastatic estrogen receptor, strategies for teaching non-science communication skills to pharmaceutical sciences doctoral students, and the impact of gene expression signatures on the discovery of cancer drugs. In addition, many Black Lab students have been accepted into fellowship programs. Other accomplishments of the lab include an invitation to present clinical study findings at the American Society of Clinical Oncology and Experimental Biology 2015.


No comments yet

Leave Comment

Only registered Worky members can comment on Blog Posts.
Register and Comment on Sherif Mohamed El-Refai's Blog post